Association between urate-lowering therapy and cardiovascular events in patients with asymptomatic hyperuricemia

被引：0
|
作者：
Hiroyuki Hashimoto
Masato Takeuchi
Koji Kawakami
机构：
[1] Kyoto University,Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health
来源：
Clinical Rheumatology | 2023年 / 42卷
关键词：
Allopurinol; Cardiovascular risk; Epidemiology; Febuxostat; Gout; Hyperuricemia; Xanthine oxidase inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3075 / 3082
页数：7
相关论文
共 50 条
  • [31] Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
    Viggiano, Davide
    Gigliotti, Giuseppe
    Vallone, Gianfranco
    Giammarino, Anna
    Nigro, Michelangelo
    Capasso, Giovambattista
    KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (02) : 606 - 615
  • [32] Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Chang, Chia-Ling
    Yang, Chen-Chang
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2021, 18 (12): : 2599 - 2606
  • [33] Urate-lowering therapy for patients with gout on hemodialysis
    Alkilany, Reem
    Einstadter, Douglas
    Antonelli, Maria
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (07) : 769 - 774
  • [34] Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study
    Kataoka, Hiroshi
    Mochizuki, Toshio
    Ohara, Mamiko
    Tsuruta, Yuki
    Iwasa, Naomi
    Yoshida, Rie
    Tsuchiya, Ken
    Nitta, Kosaku
    Kimura, Kenjiro
    Hosoya, Tatsuo
    SCIENTIFIC REPORTS, 2022, 12 (01):
  • [35] Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis
    Sharma, Gaurav
    Dubey, Abhishek
    Nolkha, Nilesh
    Singh, Jasvinder A.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [36] Urate-lowering therapy in patients with hyperuricemia and heart failure: A retrospective cohort study using the UK Clinical Practice Research Datalink
    Kiddle, Steven J.
    Sundell, Karolina Andersson
    Perl, Shira
    Nolan, Stephen
    Bjursell, Magnus
    CLINICAL CARDIOLOGY, 2024, 47 (06)
  • [37] Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial
    Mikuls, Ted R.
    Cheetham, T. Craig
    Levy, Gerald D.
    Rashid, Nazia
    Kerimian, Artak
    Low, Kimberly J.
    Coburn, Brian W.
    Redden, David T.
    Saag, Kenneth G.
    Foster, P. Jeffrey
    Chen, Lang
    Curtis, Jeffrey R.
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (03) : 354 - 361
  • [38] Factors associated with initiation and persistence of urate-lowering therapy
    Dehlin, Mats
    Ekstrom, Emin Hoxha
    Petzold, Max
    Stromberg, Ulf
    Telg, Gunilla
    Jacobsson, Lennart T. H.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [39] Prophylaxis for acute gout flares after initiation of urate-lowering therapy
    Latourte, Augustin
    Bardin, Thomas
    Richette, Pascal
    RHEUMATOLOGY, 2014, 53 (11) : 1920 - 1926
  • [40] Cardiac and renal protective effects of urate-lowering therapy
    Richette, Pascal
    Latourte, Augustin
    Bardin, Thomas
    RHEUMATOLOGY, 2018, 57 : i47 - i50
12345